SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Advanced Enzyme rises on completing additional investment in subsidiary company

11 Jul 2018 Evaluate

Advanced Enzyme Technologies is currently trading at Rs. 218.65, up by 2.45 points or 1.13% from its previous closing of Rs. 216.20 on the BSE.

The scrip opened at Rs. 218.00 and has touched a high and low of Rs. 219.25 and Rs. 217.00 respectively. So far 4588 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 361.00 on 11-Jul-2017 and a 52 week low of Rs. 205.30 on 06-Jun-2018.

Last one week high and low of the scrip stood at Rs. 219.25 and Rs. 208.50 respectively. The current market cap of the company is Rs. 2413.85 crore.

The promoters holding in the company stood at 71.32%, while Institutions and Non-Institutions held 7.19% and 21.49% respectively.

Advanced Enzyme Technologies has completed the additional investment of (Malaysian Ringgit) MYR 100,000 (around Rs 17 lakh) by way of subscription to the Right Issue of 100,000 equity shares having face value of MYR 1 each of the company’s subsidiary -- Advanced Enzymes (Malaysia) Sdn. Bhd.

In view of the aforesaid, the paid-up share capital of AEM has increased from existing MYR 400,000 to MYR 500,000.

Advanced Enzyme Technologies is an India based company engaged in research, development, manufacturing and marketing of Healthcare, Nutrition and Bio-Processing products.

Advanced Enzyme Share Price

298.60 -0.40 (-0.13%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×